Reviews Strattera


No reviews yet.

Strattera Drug Description
STRATTERA®
(atomoxetine hydrochloride) Capsules for Oral Use

WARNING
SUICIDAL IDEATION IN CHILDREN AND ADOLESCENTS
STRATTERA (atomoxetine) increased the risk of suicidal ideation in short-term
studies in children or adolescents with Attention-Deficit/Hyperactivity Disorder
(ADHD). Anyone considering the use of STRATTERA in a child or adolescent must
balance this risk with the clinical need. Co-morbidities occurring with ADHD
may be associated with an increase in the risk of suicidal ideation and/or behavior.
Patients who are started on therapy should be monitored closely for suicidality
(suicidal thinking and behavior), clinical worsening, or unusual changes in
behavior. Families and caregivers should be advised of the need for close observation
and communication with the prescriber. STRATTERA is approved for ADHD in pediatric
and adult patients. STRATTERA is not approved for major depressive disorder.

Pooled analyses of short-term (6 to 18 weeks) placebo-controlled trials
of STRATTERA in children and adolescents (a total of 12 trials involving over
2200 patients, including 11 trials in ADHD and 1 trial in enuresis) have revealed
a greater risk of suicidal ideation early during treatment in those receiving
STRATTERA compared to placebo. The average risk of suicidal ideation in patients
receiving STRATTERA was 0.4% (5/1357 patients), compared to none in placebo-treated
patients (851 patients). No suicides occurred in these trials [see WARNINGS AND PRECAUTIONS].

DRUG DESCRIPTION



What are the possible side effects of atomoxetine (Strattera)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop taking atomoxetine and call your doctor at once if you have a serious side effect such as:

chest pain, shortness of breath, fast or uneven heartbeats;
feeling light-headed or fainting;
unusual thoughts or behavior, aggression, hallucinations (seeing things that are not there);
nausea, stomach...
Read All Potential Side Effects for Strattera »




STRATTERA® (atomoxetine HCl) is a selective norepinephrine reuptake inhibitor.
Atomoxetine HCl is the R(-) isomer as determined by x-ray diffraction. The chemical
designation is (-)-N-Methyl-3-phenyl-3-(o-tolyloxy)-propylamine hydrochloride.
The molecular formula is C17H21NO•HCl, which corresponds
to a molecular weight of 291.82. The chemical structure is:








Atomoxetine HCl is a white to practically white solid, which has a solubility
of 27.8 mg/mL in water.
STRATTERA capsules are intended for oral administration only.
Each capsule contains atomoxetine HCl equivalent to 10, 18, 25, 40, 60, 80,
or 100 mg of atomoxetine. The capsules also contain pregelatinized starch and
dimethicone. The capsule shells contain gelatin, sodium lauryl sulfate, and
other inactive ingredients. The capsule shells also contain one or more of the
following:
FD&C Blue No. 2, synthetic yellow iron oxide, titanium dioxide, red iron
oxide. The capsules are imprinted with edible black ink.
Last reviewed on RxList: 8/20/2010




Strattera Drug Description
STRATTERA®
(atomoxetine hydrochloride) Capsules for Oral Use

WARNING
SUICIDAL IDEATION IN CHILDREN AND ADOLESCENTS
STRATTERA (atomoxetine) increased the risk of suicidal ideation in short-term
studies in children or adolescents with Attention-Deficit/Hyperactivity Disorder
(ADHD). Anyone considering the use of STRATTERA in a child or adolescent must
balance this risk with the clinical need. Co-morbidities occurring with ADHD
may be associated with an increase in the risk of suicidal ideation and/or behavior.
Patients who are started on therapy should be monitored closely for suicidality
(suicidal thinking and behavior), clinical worsening, or unusual changes in
behavior. Families and caregivers should be advised of the need for close observation
and communication with the prescriber. STRATTERA is approved for ADHD in pediatric
and adult patients. STRATTERA is not approved for major depressive disorder.

Pooled analyses of short-term (6 to 18 weeks) placebo-controlled trials
of STRATTERA in children and adolescents (a total of 12 trials involving over
2200 patients, including 11 trials in ADHD and 1 trial in enuresis) have revealed
a greater risk of suicidal ideation early during treatment in those receiving
STRATTERA compared to placebo. The average risk of suicidal ideation in patients
receiving STRATTERA was 0.4% (5/1357 patients), compared to none in placebo-treated
patients (851 patients). No suicides occurred in these trials [see WARNINGS AND PRECAUTIONS].

DRUG DESCRIPTION



What are the possible side effects of atomoxetine (Strattera)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop taking atomoxetine and call your doctor at once if you have a serious side effect such as:

chest pain, shortness of breath, fast or uneven heartbeats;
feeling light-headed or fainting;
unusual thoughts or behavior, aggression, hallucinations (seeing things that are not there);
nausea, stomach...
Read All Potential Side Effects for Strattera »




STRATTERA® (atomoxetine HCl) is a selective norepinephrine reuptake inhibitor.
Atomoxetine HCl is the R(-) isomer as determined by x-ray diffraction. The chemical
designation is (-)-N-Methyl-3-phenyl-3-(o-tolyloxy)-propylamine hydrochloride.
The molecular formula is C17H21NO•HCl, which corresponds
to a molecular weight of 291.82. The chemical structure is:








Atomoxetine HCl is a white to practically white solid, which has a solubility
of 27.8 mg/mL in water.
STRATTERA capsules are intended for oral administration only.
Each capsule contains atomoxetine HCl equivalent to 10, 18, 25, 40, 60, 80,
or 100 mg of atomoxetine. The capsules also contain pregelatinized starch and
dimethicone. The capsule shells contain gelatin, sodium lauryl sulfate, and
other inactive ingredients. The capsule shells also contain one or more of the
following:
FD&C Blue No. 2, synthetic yellow iron oxide, titanium dioxide, red iron
oxide. The capsules are imprinted with edible black ink.
Last reviewed on RxList: 8/20/2010




Strattera Drug Description
STRATTERA®
(atomoxetine hydrochloride) Capsules for Oral Use

WARNING
SUICIDAL IDEATION IN CHILDREN AND ADOLESCENTS
STRATTERA (atomoxetine) increased the risk of suicidal ideation in short-term
studies in children or adolescents with Attention-Deficit/Hyperactivity Disorder
(ADHD). Anyone considering the use of STRATTERA in a child or adolescent must
balance this risk with the clinical need. Co-morbidities occurring with ADHD
may be associated with an increase in the risk of suicidal ideation and/or behavior.
Patients who are started on therapy should be monitored closely for suicidality
(suicidal thinking and behavior), clinical worsening, or unusual changes in
behavior. Families and caregivers should be advised of the need for close observation
and communication with the prescriber. STRATTERA is approved for ADHD in pediatric
and adult patients. STRATTERA is not approved for major depressive disorder.

Pooled analyses of short-term (6 to 18 weeks) placebo-controlled trials
of STRATTERA in children and adolescents (a total of 12 trials involving over
2200 patients, including 11 trials in ADHD and 1 trial in enuresis) have revealed
a greater risk of suicidal ideation early during treatment in those receiving
STRATTERA compared to placebo. The average risk of suicidal ideation in patients
receiving STRATTERA was 0.4% (5/1357 patients), compared to none in placebo-treated
patients (851 patients). No suicides occurred in these trials [see WARNINGS AND PRECAUTIONS].

DRUG DESCRIPTION



What are the possible side effects of atomoxetine (Strattera)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop taking atomoxetine and call your doctor at once if you have a serious side effect such as:

chest pain, shortness of breath, fast or uneven heartbeats;
feeling light-headed or fainting;
unusual thoughts or behavior, aggression, hallucinations (seeing things that are not there);
nausea, stomach...
Read All Potential Side Effects for Strattera »




STRATTERA® (atomoxetine HCl) is a selective norepinephrine reuptake inhibitor.
Atomoxetine HCl is the R(-) isomer as determined by x-ray diffraction. The chemical
designation is (-)-N-Methyl-3-phenyl-3-(o-tolyloxy)-propylamine hydrochloride.
The molecular formula is C17H21NO•HCl, which corresponds
to a molecular weight of 291.82. The chemical structure is:








Atomoxetine HCl is a white to practically white solid, which has a solubility
of 27.8 mg/mL in water.
STRATTERA capsules are intended for oral administration only.
Each capsule contains atomoxetine HCl equivalent to 10, 18, 25, 40, 60, 80,
or 100 mg of atomoxetine. The capsules also contain pregelatinized starch and
dimethicone. The capsule shells contain gelatin, sodium lauryl sulfate, and
other inactive ingredients. The capsule shells also contain one or more of the
following:
FD&C Blue No. 2, synthetic yellow iron oxide, titanium dioxide, red iron
oxide. The capsules are imprinted with edible black ink.
Last reviewed on RxList: 8/20/2010




Strattera Drug Description
STRATTERA®
(atomoxetine hydrochloride) Capsules for Oral Use

WARNING
SUICIDAL IDEATION IN CHILDREN AND ADOLESCENTS
STRATTERA (atomoxetine) increased the risk of suicidal ideation in short-term
studies in children or adolescents with Attention-Deficit/Hyperactivity Disorder
(ADHD). Anyone considering the use of STRATTERA in a child or adolescent must
balance this risk with the clinical need. Co-morbidities occurring with ADHD
may be associated with an increase in the risk of suicidal ideation and/or behavior.
Patients who are started on therapy should be monitored closely for suicidality
(suicidal thinking and behavior), clinical worsening, or unusual changes in
behavior. Families and caregivers should be advised of the need for close observation
and communication with the prescriber. STRATTERA is approved for ADHD in pediatric
and adult patients. STRATTERA is not approved for major depressive disorder.

Pooled analyses of short-term (6 to 18 weeks) placebo-controlled trials
of STRATTERA in children and adolescents (a total of 12 trials involving over
2200 patients, including 11 trials in ADHD and 1 trial in enuresis) have revealed
a greater risk of suicidal ideation early during treatment in those receiving
STRATTERA compared to placebo. The average risk of suicidal ideation in patients
receiving STRATTERA was 0.4% (5/1357 patients), compared to none in placebo-treated
patients (851 patients). No suicides occurred in these trials [see WARNINGS AND PRECAUTIONS].

DRUG DESCRIPTION



What are the possible side effects of atomoxetine (Strattera)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop taking atomoxetine and call your doctor at once if you have a serious side effect such as:

chest pain, shortness of breath, fast or uneven heartbeats;
feeling light-headed or fainting;
unusual thoughts or behavior, aggression, hallucinations (seeing things that are not there);
nausea, stomach...
Read All Potential Side Effects for Strattera »




STRATTERA® (atomoxetine HCl) is a selective norepinephrine reuptake inhibitor.
Atomoxetine HCl is the R(-) isomer as determined by x-ray diffraction. The chemical
designation is (-)-N-Methyl-3-phenyl-3-(o-tolyloxy)-propylamine hydrochloride.
The molecular formula is C17H21NO•HCl, which corresponds
to a molecular weight of 291.82. The chemical structure is:








Atomoxetine HCl is a white to practically white solid, which has a solubility
of 27.8 mg/mL in water.
STRATTERA capsules are intended for oral administration only.
Each capsule contains atomoxetine HCl equivalent to 10, 18, 25, 40, 60, 80,
or 100 mg of atomoxetine. The capsules also contain pregelatinized starch and
dimethicone. The capsule shells contain gelatin, sodium lauryl sulfate, and
other inactive ingredients. The capsule shells also contain one or more of the
following:
FD&C Blue No. 2, synthetic yellow iron oxide, titanium dioxide, red iron
oxide. The capsules are imprinted with edible black ink.
Last reviewed on RxList: 8/20/2010




Strattera Drug Description
STRATTERA®
(atomoxetine hydrochloride) Capsules for Oral Use

WARNING
SUICIDAL IDEATION IN CHILDREN AND ADOLESCENTS
STRATTERA (atomoxetine) increased the risk of suicidal ideation in short-term
studies in children or adolescents with Attention-Deficit/Hyperactivity Disorder
(ADHD). Anyone considering the use of STRATTERA in a child or adolescent must
balance this risk with the clinical need. Co-morbidities occurring with ADHD
may be associated with an increase in the risk of suicidal ideation and/or behavior.
Patients who are started on therapy should be monitored closely for suicidality
(suicidal thinking and behavior), clinical worsening, or unusual changes in
behavior. Families and caregivers should be advised of the need for close observation
and communication with the prescriber. STRATTERA is approved for ADHD in pediatric
and adult patients. STRATTERA is not approved for major depressive disorder.

Pooled analyses of short-term (6 to 18 weeks) placebo-controlled trials
of STRATTERA in children and adolescents (a total of 12 trials involving over
2200 patients, including 11 trials in ADHD and 1 trial in enuresis) have revealed
a greater risk of suicidal ideation early during treatment in those receiving
STRATTERA compared to placebo. The average risk of suicidal ideation in patients
receiving STRATTERA was 0.4% (5/1357 patients), compared to none in placebo-treated
patients (851 patients). No suicides occurred in these trials [see WARNINGS AND PRECAUTIONS].

DRUG DESCRIPTION



What are the possible side effects of atomoxetine (Strattera)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop taking atomoxetine and call your doctor at once if you have a serious side effect such as:

chest pain, shortness of breath, fast or uneven heartbeats;
feeling light-headed or fainting;
unusual thoughts or behavior, aggression, hallucinations (seeing things that are not there);
nausea, stomach...
Read All Potential Side Effects for Strattera »




STRATTERA® (atomoxetine HCl) is a selective norepinephrine reuptake inhibitor.
Atomoxetine HCl is the R(-) isomer as determined by x-ray diffraction. The chemical
designation is (-)-N-Methyl-3-phenyl-3-(o-tolyloxy)-propylamine hydrochloride.
The molecular formula is C17H21NO•HCl, which corresponds
to a molecular weight of 291.82. The chemical structure is:








Atomoxetine HCl is a white to practically white solid, which has a solubility
of 27.8 mg/mL in water.
STRATTERA capsules are intended for oral administration only.
Each capsule contains atomoxetine HCl equivalent to 10, 18, 25, 40, 60, 80,
or 100 mg of atomoxetine. The capsules also contain pregelatinized starch and
dimethicone. The capsule shells contain gelatin, sodium lauryl sulfate, and
other inactive ingredients. The capsule shells also contain one or more of the
following:
FD&C Blue No. 2, synthetic yellow iron oxide, titanium dioxide, red iron
oxide. The capsules are imprinted with edible black ink.
Last reviewed on RxList: 8/20/2010





Other reviews about Strattera on wordpress

Day 6 on Strattera
  by mrtheo
Day 6 on Strattera How I feel Well today I felt like the days without medicine. Except that I also felt really tired again. I did not feel any effect from the […]


Day 7 on Strattera
  by mrtheo
Day 7 on Strattera How I feel Today I started for the first time with a double dose Strattera. I started a week ago with 40 mg, so now it is […]


New ADHD Drug Strattera
  by Mark
A new drug for the treatment of attention deficit hyperactivity disorder (ADHD) will be listed from 1 July 2007 on the Pharmaceutical Benefits Scheme (PBS). The drug, Strattera® (atomoxetine), […]


Study Suggests Strattera(R) Improved ADHD Symptoms In Patients With Comorbid Alcohol Abuse
  by Mark
Data from a recent clinical study showed Strattera(R) (atomoxetine HCl) improved symptoms of Attention- Deficit/Hyperactivity Disorder (ADHD) in patients with comorbid alcohol abuse disorder, suggesting ADHD can be […]


ADHD, Lilly, and Resurecting Strattera
  by kurtglmft
Missed this story in the Indianapolis Star a few days ago about Lilly's attempts to revitalize Stratera.  It made me chuckle, because as I saw the headline I […]


add adult strattera
  by siazzxgrinama
Youd meet a guy you really liked and had great conversation with, but add adult strattera the sexual connection wasnt that great. Invite friends Contact us Terms […]


add adult strattera vs wellbutrin
  by siazzxgrinama
I felt extremely nervous and awkward afterwards-I m also afraid I ve scared add adult strattera vs wellbutrin her in a stalker type way. However in general […]


KBL: Boniva and Strattera
  by Kissowa
We pondered just writing "It's smexy, buy it" for this weeks release, but figured it might come of as lazy... So, say hello to Boniva, a stunning set of […]


Top Ten Reasons To Stop Max's Strattera...
  by Mindy Hester
[caption id="attachment_304" align="alignright" width="300" caption="My sweet, kind, loving little man. I want him back. "][/caption] 1. I hate you, Mommy! 2. I wish you would go to the hospital and […]


Our trial with Strattera
  by changingdirections
After a bad experience with a paediatrician in Central Queensland , we dediced to bite the bullet adn try again - after several ongoing problems with socialization and concentration at […]



Other reviews about Strattera on web:

Strattera is indicated for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children aged 6 and older, teens, and adults. Atomoxetine (Strattera) from Eli Lilly


"On 15 September 2005 the MHRA was informed by the Marketing Authorisation Holder for Strattera (Eli Lilly) of an analysis of double blind, randomised, placebo-controlled clinical ... Atomoxetine - Wikipedia, the free encyclopedia


Learn about the prescription medication Strattera (Atomoxetine HCl), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Strattera (Atomoxetine HCl) Drug Information: Uses, Side Effects ...


Accurate, FDA approved Strattera information for healthcare professionals and patients - brought to you by Drugs.com. Strattera Official FDA information, side effects and uses.


Strattera (atomoxetine) is used to treat attention deficit hyperactivity disorder. Includes Strattera side effects, interactions and indications. Strattera Information from Drugs.com


Strattera Questions including "Does Strattera cause mood swings" and "What can you do if taking Strattera makes it difficult to sleep" WikiAnswers - Strattera Questions including "Does Strattera cause ...


Strattera lawyer representing patients who have suffered from liver disease, liver failure or any other serious side effects. Free Strattera lawsuit case evaluation offered. Strattera Liver Disease Side Effects Lawsuit


Strattera Strattera (Atomoxetine) is used for treating attention deficit hyperactivity disorder (ADHD). Buy Strattera


Buy Strattera (Atomoxetine Hcl) from our Canadian Online Pharmacy by calling 1-877-888-3562. Fully licensed, fast delivery, free doctor consultation provided. Buy Strattera (Atomoxetine Hcl) Online Now


Atomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD). It is sold in the... Strattera: 1137 user reviews - DailyStrength





Featured Reviews

Reviews Benzonatate

Benzonatate Drug Description Benzonatate Capsules USP 100mg Softgels (Soft Gelatin Capsules) DRUG DESCRIPTION Benzonatate, a nonnarcotic oral antitussive agent, is 2,5,8,11,14,17,20, 23,26- nonaoxaoctacosan-28-yl-p-(butylamino) benzoate;...
Read More  |  Review This
Reviews Tigan Injection

Tigan Injection Drug Description Tigan® (trimethobenzamide hydrochloride) Injectable For Intramuscular Use Only Not for Use in Pediatric Patients DRUG DESCRIPTION Chemically, trimethobenzamide HCl is N-[p-[2-(dimethylamino)ethoxy]benzyl]-3,4,5...
Read More  |  Review This
Reviews Darbepoetin Alfa

Aranesp Drug Description Aranesp® (darbepoetin alfa) For Injection WARNINGS INCREASED MORTALITY, SERIOUS CARDIOVASCULAR EVENTS, THROMBOEMBOLIC EVENTS, STROKE and INCREASED RISK OF TUMOR PROGRESSION OR RECURRENCE Chronic Renal...
Read More  |  Review This
Reviews Akten

Akten Drug Description Akten™ (lidocaine hydrochloride) Ophthalmic Gel 3.5% DRUG DESCRIPTION Akten™ (lidocaine hydrochloride ophthalmic gel) 3.5% is a sterile, preservative-free, single patient use ophthalmic gel preparation...
Read More  |  Review This
Reviews Reglan Injection

Reglan Injection Drug Description REGLAN Injection (metoclopramide) Injection, USP WARNING: TARDIVE DYSKINESIA Treatment with metoclopramide can cause tardive dyskinesia, a serious movement disorder that is often irreversible. The...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....